Clinical Translational Core (Core B)

Clinical Translational Core (Core B)

Translational Core
(Core B)

Core B is a bridge between basic and clinical scientists who aim to advance the translational impact of their research on neurodevelopmental disabilities. The core provides essential recruitment and phenotyping services, with more intensive support for basic scientists who may be less familiar with conducting human studies. The core also develops innovative resources to advance translational IDD science.

  • Recruitment Services

    Provides expertise on communicating recruitment needs to families and different disability communities in ways that optimize success via print materials, web, media, social media, and clinics and programs at the institutional, community, state, and national levels. Includes Studies-in-Schools consultation, IDD Sub-Registry of ResearchMatch, and StudyFinder.

  • Research Registries, Epidemiological Database Services, and Database Mining

    Provides access to the Autism Research Registry, Down Syndrome Research Registry, and State of Tennessee epidemiological databases to facilitate translational research on specific neurodevelopmental disabilities.

  • Neurobehavioral Phenotyping and Outcomes

    Facilitates the best fit of tests and measures to answer study questions via test consultation and training, and use of behavioral observational software in both animal and human studies.

  • Human Study and Clinical Trial Services

    Consultation services available to all IDDRC investigators but especially designed to assist basic scientists as they translate their findings into new studies or trials with humans.

Attention Investigators!

If you make use of these services or facilities, please acknowledge this support in publications, as required by the EKS NICHD.

Sample: "Research supported in this publication was supported by the EKS NICHD of the NIH under Award #U54HD083211. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH."

Key Personnel